Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age21-60
SponsorAl-Azhar University
About this trial
The aim of this work was to compare the efficacy of intravenous (IV) tramadol versus magnesium sulphate added to 100 ml saline for prevention of shivering associated with spinal anesthesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
history of uncontrolled comorbidities, cardiac, respiratory, renal or hepatic disease, patients who had allergy to any medication in the study, contraindications to spinal anesthesia (coagulation disorder, infection at site of puncture, raised intracranial tension or any spine deformity), fever >38 Celsius or less than 36 Celsius, body mass index more than 35 and who has history of alcohol intake
Trial design
Design model
Parallel
Treatments tested in this trial
Tramadol
DrugIntravenous tramadol
Magnesium sulphate
DrugIntravenous magnesium sulphate
Saline
Other interventionNormal saline
Treatment groups
180 Participants
are divided into 3 treatment groupsGroup A: Tramadol groupExperimental treatment 1 intervention
Group B: Magnesium sulphate groupExperimental treatment 1 intervention
Group C: Control groupPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
Shivering score
Shivering score
Time frame
90 minutes postoperativelyLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: